Invesco Ltd. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$14,371,028
+1.3%
14,627,0000.0%0.00%
-20.0%
Q3 2022$14,188,000
-0.1%
14,627,0000.0%0.01%
+25.0%
Q2 2022$14,197,000
-1.0%
14,627,0000.0%0.00%0.0%
Q1 2022$14,344,000
-0.5%
14,627,0000.0%0.00%
+33.3%
Q4 2021$14,417,000
+0.3%
14,627,0000.0%0.00%
-25.0%
Q3 2021$14,371,000
-0.1%
14,627,0000.0%0.00%0.0%
Q2 2021$14,380,000
+2.0%
14,627,0000.0%0.00%0.0%
Q1 2021$14,101,000
+1.7%
14,627,0000.0%0.00%0.0%
Q4 2020$13,871,000
+3.0%
14,627,0000.0%0.00%
-20.0%
Q3 2020$13,473,000
+4.7%
14,627,0000.0%0.01%0.0%
Q2 2020$12,873,000
+9.6%
14,627,0000.0%0.01%0.0%
Q1 2020$11,745,000
-11.3%
14,627,0000.0%0.01%
+25.0%
Q4 2019$13,240,000
-2.3%
14,627,0000.0%0.00%0.0%
Q3 2019$13,546,000
+44.2%
14,627,000
+51.9%
0.00%
+100.0%
Q2 2019$9,395,0009,627,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 37,347,000$36,345,0004.44%
CAMDEN ASSET MANAGEMENT L P /CA 51,663,000$49,804,0002.44%
Wellesley Asset Management 19,638$19,107,0002.29%
Radcliffe Capital Management, L.P. 58,877,000$56,759,0002.26%
DeepCurrents Investment Group LLC 29,151,000$28,254,0000.97%
Penn Mutual Asset Management, LLC 675,000$651,0000.74%
SHENKMAN CAPITAL MANAGEMENT INC 6,212,000$6,056,0000.71%
Sonora Investment Management, LLC 5,775,000$5,568,0000.44%
OAKTREE CAPITAL MANAGEMENT LP 22,802,000$22,095,0000.31%
WOLVERINE ASSET MANAGEMENT LLC 23,405,000$22,701,0000.19%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders